Biosimilars Boosted By Australian Initiatives
Market Share Close To A Quarter Following Educational Efforts
Executive Summary
Australia has reaped the rewards of outreach efforts on biosimilars, according to the country’s GBMA off-patent industry association, with the market share enjoyed by biosimilar medicines rising significantly in the two years since Australia’s government issued a grant for educational activities. In future, the GBMA’s Biosimilar Awareness Week could be used as the model for a global biosimilars campaign backed by the IGBA.
You may also be interested in...
Australia Rolls Out Second ‘Biosimilars Week’
A series of educational events and messages are being rolled out by Australia’s GBMA industry association as part of “Biosimilar Awareness Week.”
Australian Initiative Aims To Educate On Biosimilars
Australia’s GBMA is rolling out its second annual “Biosimilar Week” later this month as part of a three-year education program being pursued by the association and industry stakeholders.
Australia issues grant to bolster biosimilars
A ‘biosimilar education grant’ of A$5 million (US$3.8 million) has been awarded by Australia’s government to the country’s Generic and Biosimilar Medicines Association (GBMA) to “complement and extend” activities being undertaken as part of the country’s biosimilar awareness initiative.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: